Lv71
3610 积分 2024-02-08 加入
A Phase II Trial of Bendamustine, Bortezomib, and Rituximab in Patients with Previously Untreated Low Grade Lymphoma
4天前
求助中
Survival of patients with marginal zone lymphoma
1个月前
已关闭
The Treatment of Marginal Zone Lymphoma
1个月前
已完结
Management of relapsed or refractory large B‐cell lymphoma: A British Society for Haematology Guideline
2个月前
已完结
CAR-T cell therapy in the treatment of relapsed or refractory primary central nervous system lymphoma: recent advances and challenges
5个月前
已完结
Advances in Primary Central Nervous System Lymphoma
5个月前
已完结
EBV‐positive diffuse large B‐cell lymphoma, not otherwise specified: 2024 update on the diagnosis, risk‐stratification, and management
7个月前
已完结
Primary Large B-cell Lymphomas of Immune-Privileged Sites
8个月前
已完结
Primary Large B-cell Lymphomas of Immune-Privileged Sites
8个月前
已关闭
Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma
9个月前
已完结
皖公网安备34019202002308
